Cerebrospinal fluid levels of NfM in relation to NfL and pNfH as prognostic markers in amyotrophic lateral sclerosis
Based on this cross-sectional study, the prognostic value provided by NfM aligns with the more established markers, NfL and pNfH. Additional investigations with independent cohorts and longitudinal studies are needed to further assess the potential added value of NfM.
Authors
- Jennie Olofsson
- Sára Mravinacová
- Kaj Blennow (ORCID: https://orcid.org/0000-0002-1890-4193)
- Anna Månberg (ORCID: https://orcid.org/0000-0002-0056-1313)
- Linn Öijerstedt (ORCID: https://orcid.org/0000-0003-0635-6377)
- Caroline Ingre (ORCID: https://orcid.org/0000-0001-5327-7204)
- Ulf Kläppe (ORCID: https://orcid.org/0000-0001-5832-038X)
- Henrik Zetterberg (ORCID: https://orcid.org/0000-0003-3930-4354)
- Peter Nilsson (ORCID: https://orcid.org/0000-0002-4657-8532)
- Sofia Bergström (ORCID: https://orcid.org/0000-0003-2910-4754)
Institutions
- University of Science and Technology of China (CN)
- Karolinska University Hospital (SE)
- University of Wisconsin–Madison (US)
- Science for Life Laboratory (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Sorbonne Université (FR)
- Pitié-Salpêtrière Hospital (FR)
- UK Dementia Research Institute (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- Institut du Cerveau (FR)
- University College London (GB)
- KTH Royal Institute of Technology (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1080/21678421.2024.2428930
- Citations
- 4
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 1.48
Funders
- Alzheimer's Drug Discovery Foundation
- Vetenskapsrådet